PTIX
Protagenic Therapeutics, Inc.1.5200
-0.0699-4.4%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
2.93MP/E (TTM)
-Basic EPS (TTM)
-13.13Dividend Yield
0%Recent Filings
10-Q
8-K
8-K
8-K
8-K
Nasdaq delisting notice issued
Protagenic Therapeutics received a Nasdaq delisting notice on November 20, 2025, for failing the $2.5 million stockholders' equity rule and delayed 10-Q filing. Fresh off recent compliance, it's now under mandatory monitoring—staff moved to delist. Company plans immediate hearing appeal; trading stays for 15 days automatically. No guarantee Panel grants extension.
CPMV
Mosaic ImmunoEngineering Inc.
0.40+0.00
EPIX
ESSA Pharma Inc.
0.20+0.00
IMA
ImageneBio, Inc.
6.25+0.08
PKTX
ProtoKinetix, Inc.
0.00+0.00
PLX
Protalix BioTherapeutics, Inc.
1.81+0.07
PNXP
Pineapple Express Cannabis Comp
0.01+0.00
PPCB
Propanc Biopharma, Inc.
0.73-0.03
PTGX
Protagonist Therapeutics, Inc.
91.54-3.25
TARA
Protara Therapeutics, Inc.
5.42-0.08
XCUR
Exicure, Inc.
6.06+0.33